217 related articles for article (PubMed ID: 34498424)
41. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
42. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
43. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
Zhen Z; Shen Z; Hu Y; Sun P
Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
[TBL] [Abstract][Full Text] [Related]
44. Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer.
Mei Y; Jiang P; Shen N; Fu S; Zhang J
DNA Cell Biol; 2020 Jun; 39(6):1023-1040. PubMed ID: 32349536
[TBL] [Abstract][Full Text] [Related]
45. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
46. Identification of Key Pathways and Establishment of a Seven-Gene Prognostic Signature in Cervical Cancer.
An R; Meng S; Qian H
J Oncol; 2022; 2022():4748796. PubMed ID: 35154316
[TBL] [Abstract][Full Text] [Related]
47. Identification of an immune-based mRNA-lncRNA signature for overall survival in cervical squamous cell carcinoma.
Mao Y; Chen R; Xia M; Guo P; Zeng F; Huang J; He M
Future Oncol; 2021 Jun; 17(18):2365-2380. PubMed ID: 33724869
[TBL] [Abstract][Full Text] [Related]
48. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
49. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
51. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
Xue Y; Li J; Lu X
Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760
[TBL] [Abstract][Full Text] [Related]
52. Identification and validation of a prognostic signature related to hypoxic tumor microenvironment in cervical cancer.
Nie C; Qin H; Zhang L
PLoS One; 2022; 17(6):e0269462. PubMed ID: 35657977
[TBL] [Abstract][Full Text] [Related]
53. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
54. Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC
Li X; Zhang Q; Chen G; Luo D
Front Immunol; 2021; 12():694801. PubMed ID: 34295336
[TBL] [Abstract][Full Text] [Related]
55. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
[TBL] [Abstract][Full Text] [Related]
56. Pain-Related Gene Solute Carrier Family 24 Member 3 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma: A Study via Integrated Bioinformatics Analyses and Experimental Verification.
Zhou S; Jin Q; Yao H; Ying J; Tian L; Jiang X; Yang Y; Jiang X; Gao W; Zhang W; Zhu Y; Cao W
Comput Math Methods Med; 2023; 2023():4164232. PubMed ID: 36798148
[TBL] [Abstract][Full Text] [Related]
57. Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer.
Yu S; Li X; Zhang J; Wu S
Front Immunol; 2021; 12():709493. PubMed ID: 34539641
[TBL] [Abstract][Full Text] [Related]
58. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Wang Z; Tu L; Chen M; Tong S
BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
[TBL] [Abstract][Full Text] [Related]
59. Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis.
Chen Q; Qiu B; Zeng X; Hu L; Huang D; Chen K; Qiu X
Cancer Cell Int; 2021 Mar; 21(1):182. PubMed ID: 33766042
[TBL] [Abstract][Full Text] [Related]
60. Identification of a survival-related signature for sarcoma patients through integrated transcriptomic and proteomic profiling analyses.
Zhang B; Yang L; Wang X; Fu D
Gene; 2021 Jan; 764():145105. PubMed ID: 32882333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]